{"id":"NCT00761774","sponsor":"UCB Pharma","briefTitle":"An Open-label, Multinational, Multicenter, Follow-up Study to Evaluate the Long-term Safety and Efficacy of Brivaracetam","officialTitle":"An Open-label, Multinational, Multicenter, Follow-up Study to Evaluate the Long-term Safety and Efficacy of Brivaracetam Used at a Flexible Dose up to a Maximum of 200 mg/Day in Subjects Aged 16 Years or Older Suffering From Epilepsy.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-11","primaryCompletion":"2017-03","completion":"2017-03","firstPosted":"2008-09-30","resultsPosted":"2018-04-23","lastUpdate":"2018-07-11"},"enrollment":108,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Epilepsy"],"interventions":[{"type":"DRUG","name":"Brivaracetam","otherNames":["ucb 34714"]}],"arms":[{"label":"Brivaracetam","type":"EXPERIMENTAL"}],"summary":"The Sponsor wishes to develop brivaracetam as an anti-epileptic treatment in subjects 16 years and older with epilepsy. This study permits continued access to treatment for subjects who participated in a previous epilepsy study. The study will explore the long-term safety and efficacy of brivaracetam.","primaryOutcome":{"measure":"Percentage of Subjects With at Least One Treatment-emergent Adverse Event (TEAE) During the Evaluation Period From Entry Visit 1 Through End of Treatment (up to 9 Years)","timeFrame":"During the Evaluation Period (up to 9 years)","effectByArm":[{"arm":"Brivaracetam (SS)","deltaMin":90.7,"sd":null}],"pValues":[]},"eligibility":{"minAge":"16 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":null},"locations":{"siteCount":58,"countries":["United States","Australia","Belgium","Canada","Czechia","France","Germany","Hungary","Italy","Spain","Sweden"]},"refs":{"pmids":["26899665"],"seeAlso":["https://www.briviact.com/briviact-PI.pdf?v=1479491757","http://www.fda.gov/Safety/MedWatch/SafetyInformation/default.htm"]},"adverseEventsSummary":{"seriousAny":{"events":26,"n":108},"commonTop":["Nasopharyngitis","Depression","Fatigue","Convulsion","Fall"]}}